Cargando…
Evaluation of coagulation parameters in patients with parathyroid adenoma
Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645620/ https://www.ncbi.nlm.nih.gov/pubmed/33154484 http://dx.doi.org/10.1038/s41598-020-76167-2 |
_version_ | 1783606666347937792 |
---|---|
author | Alay, Murat Ercek, Berrak Mermit Sonmez, Gulcin Miyase Sakin, Aysegul Ucler, Rifki Yildiz, Saliha |
author_facet | Alay, Murat Ercek, Berrak Mermit Sonmez, Gulcin Miyase Sakin, Aysegul Ucler, Rifki Yildiz, Saliha |
author_sort | Alay, Murat |
collection | PubMed |
description | Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and parathyroid adenoma. A prospective study included 28 female patients with parathyroid adenoma aged 40–88 years and 27 age-matched healthy controls. The coagulation parameters were assessed for each participant. The mean ages of the patient and control groups were 57.7 ± 10.9 and 53.3 ± 9.31 years, respectively. The mean level of protein S activity was 65.79 ± 13.78 in the patient group and 77.00 ± 15.72 in the control group, and the difference was statistically significant (p = 0.013). The mean fibrinogen levels of the patient and control groups were 338.78 ± 63.87 mg/dL and 304.30 ± 45.67 mg/dL, respectively, and a significant difference was found (p = 0.041). However, no significant difference was evident between the two groups with regard to the D-dimer (p = 0.238), aPTT (p = 0.645), INR (p = 0.406), protein C (p = 0.076), and AT-III (p = 0.180) levels. A positive correlation was observed between adenoma volume and fibrinogen in the patient group (r = 0.711, p = 0.001). The protein S levels were lower and the fibrinogen levels higher in the patients with parathyroid adenoma. |
format | Online Article Text |
id | pubmed-7645620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76456202020-11-06 Evaluation of coagulation parameters in patients with parathyroid adenoma Alay, Murat Ercek, Berrak Mermit Sonmez, Gulcin Miyase Sakin, Aysegul Ucler, Rifki Yildiz, Saliha Sci Rep Article Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and parathyroid adenoma. A prospective study included 28 female patients with parathyroid adenoma aged 40–88 years and 27 age-matched healthy controls. The coagulation parameters were assessed for each participant. The mean ages of the patient and control groups were 57.7 ± 10.9 and 53.3 ± 9.31 years, respectively. The mean level of protein S activity was 65.79 ± 13.78 in the patient group and 77.00 ± 15.72 in the control group, and the difference was statistically significant (p = 0.013). The mean fibrinogen levels of the patient and control groups were 338.78 ± 63.87 mg/dL and 304.30 ± 45.67 mg/dL, respectively, and a significant difference was found (p = 0.041). However, no significant difference was evident between the two groups with regard to the D-dimer (p = 0.238), aPTT (p = 0.645), INR (p = 0.406), protein C (p = 0.076), and AT-III (p = 0.180) levels. A positive correlation was observed between adenoma volume and fibrinogen in the patient group (r = 0.711, p = 0.001). The protein S levels were lower and the fibrinogen levels higher in the patients with parathyroid adenoma. Nature Publishing Group UK 2020-11-05 /pmc/articles/PMC7645620/ /pubmed/33154484 http://dx.doi.org/10.1038/s41598-020-76167-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Alay, Murat Ercek, Berrak Mermit Sonmez, Gulcin Miyase Sakin, Aysegul Ucler, Rifki Yildiz, Saliha Evaluation of coagulation parameters in patients with parathyroid adenoma |
title | Evaluation of coagulation parameters in patients with parathyroid adenoma |
title_full | Evaluation of coagulation parameters in patients with parathyroid adenoma |
title_fullStr | Evaluation of coagulation parameters in patients with parathyroid adenoma |
title_full_unstemmed | Evaluation of coagulation parameters in patients with parathyroid adenoma |
title_short | Evaluation of coagulation parameters in patients with parathyroid adenoma |
title_sort | evaluation of coagulation parameters in patients with parathyroid adenoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645620/ https://www.ncbi.nlm.nih.gov/pubmed/33154484 http://dx.doi.org/10.1038/s41598-020-76167-2 |
work_keys_str_mv | AT alaymurat evaluationofcoagulationparametersinpatientswithparathyroidadenoma AT ercekberrakmermit evaluationofcoagulationparametersinpatientswithparathyroidadenoma AT sonmezgulcinmiyase evaluationofcoagulationparametersinpatientswithparathyroidadenoma AT sakinaysegul evaluationofcoagulationparametersinpatientswithparathyroidadenoma AT uclerrifki evaluationofcoagulationparametersinpatientswithparathyroidadenoma AT yildizsaliha evaluationofcoagulationparametersinpatientswithparathyroidadenoma |